Background-Oxidative stress and mitochondrial dysfunction are central mediators of cardiac dysfunction after ischemia/ reperfusion. ATP binding cassette mitochondrial erythroid (ABC-me; ABCB10; mABC2) is a mitochondrial transporter highly induced during erythroid differentiation and predominantly expressed in bone marrow, liver, and heart. Until now, ABC-me function in heart was unknown. Several lines of evidence demonstrate that the yeast ortholog of ABC-me protects against increased oxidative stress. Therefore, ABC-me is a potential modulator of the outcome of ischemia/reperfusion in the heart. Methods and Results-Mice harboring 1 functional allele of ABC-me (ABC-me ϩ/Ϫ ) were generated by replacing ABC-me exons 2 and 3 with a neomycin resistance cassette. Cardiac function was assessed with Langendorff perfusion and echocardiography. Under basal conditions, ABC-me ϩ/Ϫ mice had normal heart structure, hemodynamic function, mitochondrial respiration, and oxidative status. However, after ischemia/reperfusion, the recovery of hemodynamic function was reduced by 50% in ABC-me ϩ/Ϫ hearts as a result of impairments in both systolic and diastolic function. This reduction was associated with impaired mitochondrial bioenergetic function and with oxidative damage to both mitochondrial lipids and sarcoplasmic reticulum calcium ATPase after reperfusion. Treatment of ABC-me ϩ/Ϫ hearts with the superoxide dismutase/catalase mimetic EUK-207 prevented oxidative damage to mitochondria and sarcoplasmic reticulum calcium ATPase and restored mitochondrial and cardiac function to wild-type levels after reperfusion. Conclusions-Inactivation of 1 allele of ABC-me increases the susceptibility to oxidative stress induced by ischemia/ reperfusion, leading to increased oxidative damage to mitochondria and sarcoplasmic reticulum calcium ATPase and to impaired functional recovery. Thus, ABC-me is a novel gene that determines the ability to tolerate cardiac ischemia/reperfusion. (Circulation. 2011;124:806-813.)
A cute coronary occlusion leading to cardiac ischemia/reperfusion is a major cause of mortality in Western societies. Multiple lines of evidence demonstrate that increased oxidative stress and mitochondrial dysfunction are key mediators of the cardiac dysfunction induced by ischemia/reperfusion. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] After ischemia/reperfusion, oxidative stress may impair mitochondrial electron transport, 2,4,8 -10 leading to decreased mitochondrial ATP synthesis and respiration and thereby contributing to diastolic stiffness and contractile dysfunction. 8 -10,16 Conversely, the sudden increase in mitochondrial respiration during early reperfusion and the impairment in electron transport chain activity may increase the production of reactive oxygen species and contribute to oxidative damage. 4, 5, 8, 12, 17 Furthermore, the opening of the mitochondrial transition pore and mitochondrial fission promote cardiac myocyte death after ischemia/reperfusion. 7, 11, 18 Clinical Perspective on p 813
The central role that oxidative stress plays in myocardial recovery from ischemia/reperfusion has been well illustrated. Targeting antioxidants to mitochondria or overexpression of global and mitochondrial antioxidant enzymes (such as catalase or superoxide dismutase sod1 and sod2) protects and improves the recovery from myocardial ischemia/reperfusion injury. 1, 6, 14, 19, 20 In contrast, partial loss of function of antioxidant enzymes (such as mitochondrial sod2) worsens the recovery from ischemia/reperfusion. 3 In the latter model, impaired recovery is independent of changes in cell viability, suggesting that oxidative stress leads to functional impairment of the contractile machinery and/or mitochondria (and the concomitant bioenergetic defect). 3 In this regard, inactivation of sarcoplasmic reticulum calcium ATPase (SERCA) by sulfonic acid oxidation of the thiol on cysteine 674 is increased after ischemia/reperfusion, impairing calcium handling and contractility in cardiomyocytes. 21, 22 In addition, increased mitochondrial lipid oxidation has been shown to be one of the main alterations decreasing the electron transport chain activity after ischemia/reperfusion. 10 Therefore, any novel gene that protects mitochondrial and/or contractile function from oxidative damage is a potential modulator of cardiac recovery after ischemia/reperfusion. ATP binding cassette mitochondrial erythroid (ABC-me, ABCB10 or mABC2) was first discovered in the erythroid tissue, where it is induced during erythroid differentiation. 23 ABC-me is a mitochondrial exporter of unknown substrate/s located in the inner mitochondrial membrane, with its nucleotide binding domain in the matrix. 23, 24 In erythroid cell lines, ABC-me has been shown to regulate hemoglobin synthesis and to stabilize mitoferrin 1, a mitochondrial iron importer. 23, 25 Although cardiac tissue is one of the main sites of ABC-me expression, its function in the heart has not been studied. 23 Therefore, it is likely that, in such nonerythroid tissues, ABC-me plays a role not directly related to hemoglobinization.
Studies of ABC-me orthologs suggest that ABC-me may alter the capacity of cells to handle oxidative stress. 26 In this study, we tested the hypothesis that ABC-me plays a role in the protection of mitochondrial and contractile functions from increased oxidative stress induced by ischemia/reperfusion in the heart. We found that hearts from mice harboring only 1 functional allele of ABC-me (ABC-me ϩ/Ϫ ) show impaired hemodynamic recovery and increased oxidative damage of both mitochondrial lipids and SERCA and exhibit severe mitochondrial dysfunction after ischemia/reperfusion. These defects were selectively restored in ABC-me ϩ/Ϫ hearts by treatment with an SOD/catalase mimetic.
Methods

Animals
ABC-me ϩ/Ϫ mice were generated by a gene-targeted knockout strategy through Lexicon Genetics (ABC-me exons 2 and 3 were replaced by a neomycin resistance cassette) on a C57BL6/ 129SvEvBrd mixed background and backcrossed up to 4 generations onto C57BL6 background ( Figure I in the online-only Data Supplement). Three-month-old male or female wild-type and ABC-me ϩ/Ϫ littermates were used (Inactivation of 1 allele of ABC-me did not cause sex-specific differences in the cardiac phenotype). Genotyping was performed by polymerase chain reaction of tail lysates. All procedures and experiments were carried out according to institutional guidelines for animal care (Institutional Animal Care and Use Committee No. 14856) at Boston University in compliance with US Public Health service regulations.
Ex Vivo Langendorff Preparations and EUK-207 Treatment
Mice were heparinized (100 U IP) and anesthetized by sodium pentobarbital (150 mg/kg IP). The heart was excised and perfused at a constant pressure of 80 mm Hg at 37°C as previously described. 27 The perfusate was equilibrated with 95% O 2 and 5% CO 2 (pH 7.4) and contained the following (in mmol/L): NaCl 118 NaHCO 3 25, KCl 5.3, CaCl 2 1.8, MgSO 4 1.2, glucose 10, and pyruvate 0.5. Hearts were paced at 7.5 Hz, maintaining a constant heart rate of 450 bpm throughout the protocol. A water-filled balloon was inserted into the left ventricle (LV) to record ventricular pressure. After stabilization, an LV pressure-volume relationship was obtained by stepwise increases in the balloon volume until the maximum LV developed pressure was reached for each heart. In a separate cohort, hearts were perfused (while LV function was recorded continuously) with either vehicle (initial concentration, 4% dextrose) or EUK 207 (50 mol/L final concentration in perfusate) for 20 minutes, followed by 2 minutes of washout, 10 minutes of no-flow global ischemia, and then 20 minutes of reperfusion (maintaining and controlling temperature at 37°C during the procedure). For ATP measurements, beating hearts were freeze-clamped with Wollenberger tongs that were precooled in liquid nitrogen. EUK-207 was custom synthesized by Dalton Chemical Laboratories (Toronto, Ontario, Canada) as previously described. 28 Purity was Ͼ98% as assessed by high-performance liquid chromatography. Identity was confirmed by nuclear magnetic resonance spectroscopy of the ligand and by elemental analysis and mass spectrometry of the Mn-ligand complex as we have described previously for salen Mn or Mn porphyrin SOD/catalase mimetics. 29 The dose selected was based on protective activity reported previously in tissue culture, 29, 30 as well as on that of another salen Mn complex, EUK-8, in an isolated perfused rat heart model. 31
Echocardiography and Tissue Doppler
Echocardiography and tissue Doppler were performed as described. 32 See the online-only Data Supplement for details.
Mitochondria Isolation
Hearts were incubated and minced in ice-cold fiber relaxation buffer (for Ϸ10 minutes; KCl 100 mmol/L, EGTA 5 mmol/L, HEPES 5 mmol/L adjusted with KOH to pH 7.4, to help releasing intermyofibrillar mitochondria), and they were homogenized in 2 mL HES buffer (HEPES 5 mmol/L, EDTA 1 mmol/L, sucrose 0.25 mol/L, pH 7.4 adjusted with KOH 1 mol/L) with a glass dounce homogenizer (20 strokes with loose pestle, 20 strokes tight pestle). The homogenate was centrifuged at 500g for 10 minutes at 4°C (The pellet was discarded and supernatant recentrifuged at 500g). The supernatant was centrifuged at 9000g for 15 minutes at 4°C, and the mitochondrial pellet was resuspended in 100 to 200 L HES buffer with 0.2% BSA fatty acid free. Protein was quantified with BCA (Pierce), and the value of protein measured in HES-BSA 0.2% buffer alone was subtracted.
Mitochondrial Oxygen Consumption Measurements
Isolated mitochondria (20 to 40 g in HES-BSA 0.2% buffer per well, nϭ3 to 4 replicates per mouse) were loaded in a V7 24-well Seahorse plate on ice and 440 L ice-cold mitochondrial assay buffer (MAS: sucrose 70 mmol/L, mannitol 220 mmol/L, KH 2 PO 4 5 mmol/L, MgCl 2 5 mmol/L, HEPES 2 mmol/L, EGTA 1 mmol/L, BSA fatty acid free 0.2%, pH 7.4 adjusted with KOH 1 mol/L) plus 50 L MAS buffer with 10ϫ substrates (complex II: succinate 50 mmol/L plus rotenone 20 mol/L; complex I: pyruvate plus malate, 50 mmol/L each) were added on top. The 4 sequential injection ports of the Seahorse cartridge contained (in MAS solution and adjusted to pH 7.4) the following: port A, 50 L of 10ϫ substrate and ADP 2.5 mmol/L; port B, 55 L oligomycin 20 mol/L; port C, 60 L of 2,4-dinitrophenol 1 mmol/L; and port D, 65 L antimycin 40 mol/L. Oxygen consumption rates were monitored in real time after the injection. State III was determined after port A injection; state IV, after port B; and uncoupled respiration rates, after port C. Antimycin A was used as a control because it blocks ETC oxygen consumption. See the online-only Data Supplement and www.shirihai-lab.org for more details.
Western Blot and Protein Carbonylation
We performed SDS-PAGE and transfer as described previously. 33 See the online-only Data Supplement for details.
Measurements of Superoxide in Isolated Mitochondria With Mitosox
This assay was adapted from Johnson-Cadwell et al 34 and performed in a 96-well microplate reader in a 200-L reaction volume. The slope of Mitosox (Invitrogen) fluorescence increase was determined between the first 5 to 30 minutes after addition of Mitosox on isolated mitochondria at 37°C.
ATP Measurements
The ATP concentrations were measured spectrophotometrically in neutralized perchloric acid filtrates as previously described 35 and normalized against total protein contents. ATP synthesis rates were measured in respiring mitochondrial fractions with the ATP Kit CLS II (Roche). See the online-only Data Supplement for additional information.
Histology to Detect Sarcoplasmic Reticulum Calcium ATPase Oxidation
This methodology was performed as described elsewhere. 21
Lipid Oxidation Measurements by Thiobarbituric Acid Reactive Substances
Isolated mitochondria (100 g) were solubilized with SDS, and nanomoles of thiobarbituric acid reactive substances per 1 mg protein were measured with the Cell Biolabs kit and following manufacturer's indications on the basis of previously reported methodologies (eg, see Reference 10).
Statistical Analysis
Nonparametric (unpaired, two-tailed) tests were used: Mann-Whitney U for nՆ4 and a test based on the Chebyshev inequality for nϭ3. Statistically significant differences and exact P values are stated in the figure legends.
Results
ABC-me ؉/؊ Hearts Have Normal Hemodynamic and Mitochondrial Function Under Basal Conditions
ABC-me Ϫ/Ϫ mice were found to be embryonic lethal (data not shown). ABC-me ϩ/Ϫ mice did not show any apparent phenotype under basal conditions, and their fertility was similar to that of wild-type mice. No differences in body weight, heart weight, or the ratio of heart weight to body weight were observed between wild-type and ABC-me ϩ/Ϫ mice (the Table) . Cardiac function was assessed by ex vivo Langendorff preparation, echocardiography, and tissue Doppler. Systolic and end-diastolic pressurevolume curves and developed pressure were similar over a range of LV volumes in wild-type and ABC-me ϩ/Ϫ hearts ( Figure  1A ). Echocardiography showed that LV end-diastolic volume, end-systolic volume, wall thickness, mass index, and fractional shortening were similar in wild-type and ABC-me ϩ/Ϫ hearts (the Table) . Tissue Doppler also revealed similar diastolic function ( Figure 1B and the Table) .
Consistent with normal hemodynamic function, the rate of mitochondrial oxygen consumption measured in the presence of substrates that drive respiration through complex I or II was also normal in ABC-me ϩ/Ϫ hearts (Figure 2A and 2B ). This was also confirmed by the lack of differences in mitochondrial structure visualized by confocal microscopy (data not shown) or in maximal respiratory capacity and respiration linked to ATP synthesis measured with the Sea- horse XF24 in intact cardiomyocytes isolated from adult ABC-me ϩ/Ϫ and wild-type mice ( Figure II in the online-only Data Supplement). In addition, under basal conditions, there was no evidence of increased oxidative stress in ABC-me ϩ/Ϫ hearts, as reflected by protein carbonylation levels ( Figure  2C ), mitochondrial superoxide production ( Figure 2D ), the upregulation of sod2 and catalase protein ( Figure 2E ), or the lack of significant detection of oxidized SERCA ( Figure 3F ).
ABC-me ؉/؊ Hearts Show Impaired Hemodynamic Recovery and Increased Oxidative Stress After Ischemia/Reperfusion
To study the role of ABC-me in the recovery from ischemia/ reperfusion, Langendorff preparations of wild-type and ABCme ϩ/Ϫ hearts were subjected to 10 minutes of global ischemia followed by 20 minutes of reperfusion. In wild-type hearts, there was a 55% recovery of developed pressure after 20 minutes of reperfusion ( Figure 3A and 3D) . In contrast, in ABC-me ϩ/Ϫ hearts, the recovery of developed pressure was markedly reduced to 27% ( Figure 3A and 3D) , in association with an increase in diastolic pressure ( Figure 3B ) and a small decrease in systolic pressure ( Figure 3C ). To test whether an alteration in the oxidative status was responsible for this impaired recovery, we measured lipid oxidation in isolated mitochondria. We observed an increase in oxidized lipids in isolated mitochondria from ABC-me ϩ/Ϫ hearts after reperfusion ( Figure 3E ). In addition, we studied SERCA oxidation because it is a protein modification linking impaired oxidative status and altered diastolic function after reperfusion. 21, 22 We detected a marked increase in oxidized SERCA in sections of ABC-me ϩ/Ϫ hearts after reperfusion using an antibody that specifically detects sulfonic acid oxidation of the thiol on SERCA cysteine 674 ( Figure 3F ). These data were confirmed by decreased biotinylated iodoacetamide labeling of SERCA (measure of total free thiol groups) in lysates from ABC-me ϩ/Ϫ hearts after reperfusion ( Figure III in the online-only Data Supplement).
A Superoxide Dismutase/Catalase Mimetic (EUK-207) Rescues Contractile and Mitochondrial Function After Ischemia/Reperfusion in ABC-me ؉/؊ Hearts
To test to which extent increased oxidative stress mediates the reduced recovery from ischemia/reperfusion in ABC-me ϩ/Ϫ hearts, 20 minutes before the start of ischemia, we perfused hearts with EUK-207, a catalytic antioxidant with catalase and SOD activities. 28 -30,36 EUK-207 pretreatment completely prevented the impairment in recovery of hemodynamic function in ABC-me ϩ/Ϫ hearts caused by ischemia/reperfusion (Figure 3 ). EUK-207 normalized end-diastolic pressure in ABC-me ϩ/Ϫ hearts to the absolute values observed in wild-type hearts ( Figure  3B ). Of note, EUK-207 increased developed and systolic pressures in both ABC-me ϩ/Ϫ hearts and wild-type hearts to similar absolute levels that exceeded that of untreated wild-type hearts (Figure 3A, 3C, and 3D) . Importantly, the degree of developed 
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pressure recovery in ABC-me ϩ/Ϫ hearts treated with EUK-207 was greater (from 27% to 90%ϭ3.3-fold increase) than in wild-type hearts (from 55% to 82%ϭ1.5-fold increase; Figure  3D ), demonstrating the selectivity of the rescue by EUK-207 in ABC-me ϩ/Ϫ hearts. To further address the mechanism leading to impaired ischemia/reperfusion recovery and to confirm the relevance of increased mitochondrial lipid oxidation in ABC-me ϩ/Ϫ hearts, we measured mitochondrial respiration rates after 20 minutes of reperfusion. Respiration measurements were made in state III (respiration linked to maximal ATP synthesis rate), state IV (respiration not linked to ATP synthesis), and uncoupled respiration (by adding 2,4-dinitrophenol, which uncouples oxygen consumption from ATP synthesis). Ischemia/reperfusion selectively decreased mitochondrial respiration rates in all states and under 2,4-dinitrophenol in ABC-me ϩ/Ϫ hearts compared with wild-type hearts, suggesting impairment of the electron transport chain ( Figure 4A ). This impairment also caused a marked decrease in mitochondrial ATP synthesis rates ( Figure 4B ). Of note, pretreatment with EUK-207 completely prevented the decrease in mitochondrial respiration caused by ischemia/reperfusion in ABCme ϩ/Ϫ hearts but had no effects on mitochondrial respiration in wild-type hearts after reperfusion ( Figure 4A ). This lack of EUK-207 effect in wild-type mitochondrial respiration demonstrated again the specificity of the mitochondrial defect in ABC-me ϩ/Ϫ hearts after reperfusion and the selectivity of its correction by EUK-207 treatment. The correction of mitochondrial respiration by EUK-207 was accompanied by complete restoration of mitochondrial ATP synthesis rates in ABC-me ϩ/Ϫ hearts ( Figure 4B ). This was associated with a marked increase in total ATP levels ( Figure 4C ). Further- pressure at the end of reperfusion vs baseline) of WT and ABC-me ϩ/Ϫ hearts (nϭ7) pretreated with vehicle or 50 mol/L EUK-207. *Pϭ0.02, WT vs ABC-me ϩ/Ϫ ; #Pϭ0.002, vehicle ABC-me ϩ/Ϫ vs EUK-207 ABC-me ϩ/Ϫ ; †Pϭ0.03, WT vs WT EUK-207. E, Quantification of lipid oxidation by thiobarbituric acid reactive substances (TBARS) in isolated mitochondria from WT and ABC-me ϩ/Ϫ hearts after ischemia/reperfusion or ABC-me ϩ/Ϫ hearts pretreated with EUK-207 or with vehicle after ischemia/reperfusion (nϭ5). All data are shown as meanϮSEM. *Pϭ0.0079, WT vs ABC-me ϩ/Ϫ ; #Pϭ0.03, vehicle ϩ/Ϫ vs EUK-207. F, Representative images of heart sections immunostained with an antibody detecting sulfonylated sarcoplasmic reticulum calcium ATPase on cysteine 674 from WT and ABC-me ϩ/Ϫ hearts under basal conditions and after ischemia/reperfusion and pretreated with EUK-207 or vehicle after ischemia/reperfusion (IR). Scale bar, 25 m. more, EUK-207 treatment prevented the increase in both SERCA and mitochondrial lipid oxidation ( Figure 3E and 3F). In addition, this increased oxidative damage caused some necrosis in ABC-me ϩ/Ϫ hearts (detected as triphenyltetrazolium chloride-unstained areas within viable tissue), which was also prevented by EUK-207 (data not shown).
Discussion
We describe, for the first time, the phenotype of the ABCme ϩ/Ϫ mouse model and a role for the mitochondrial transporter ABC-me in the recovery of cardiac function after ischemia/reperfusion. This conclusion is supported by the impaired recovery of hemodynamic function after ischemia/ reperfusion in mice having inactivation of 1 allele of ABCme. Hemodynamic dysfunction was due to abnormalities in diastolic pressure and contraction, both of which are ATP dependent and thus reliant on normal mitochondrial oxidative phosphorylation. 8, 16 In this regard, we show an impaired oxidative status in mitochondria from ABC-me ϩ/Ϫ hearts after reperfusion. This is demonstrated by the increase in mitochondrial lipid oxidation and the concomitant decrease in mitochondrial respiration and ATP synthesis rates in ABCme ϩ/Ϫ hearts after reperfusion. These results are in line with several reports showing that lipid oxidation decreases mitochondrial respiration. 8 -10 Furthermore, we also observe an increase in SERCA oxidation in ABC-me ϩ/Ϫ hearts, corroborating a lack of protection from oxidative stress induced by ischemia/reperfusion. In addition, this increased oxidative damage can explain the detection of some necrotic areas in ABC-me ϩ/Ϫ hearts. Therefore, increased oxidative stress is sufficient to explain the hemodynamic dysfunction in ABCme ϩ/Ϫ hearts after ischemia/reperfusion.
To confirm that the alteration in the oxidative status was sufficient to cause the impaired recovery from ischemia/ reperfusion in ABC-me ϩ/Ϫ hearts, they were perfused with EUK-207, a catalytic antioxidant with catalase and SOD activities. 28 -30,36 EUK-207 treatment prevented the appearance of necrotic areas and the increase in oxidation of mitochondrial lipids and SERCA. Furthermore, the functional alterations in mitochondria and contractility of ABC-me ϩ/Ϫ hearts were completely and selectively prevented by perfusion with EUK-207 shortly before the onset of ischemia. The protective effect of this SOD/catalase mimetic suggests that inactivation of 1 allele of ABC-me decreases the ability of the cardiac myocyte to protect mitochondrial and contractile function from oxidative stress in the setting of ischemia/ reperfusion. Consistent with this line of evidence, the ABC-me yeast ortholog (Mdl1p, 42% amino acid sequence similarity) protects against increased oxidative stress caused by iron accumulation in mitochondria triggered by ATM1 deletion. 26 Also consistent with our observation, partial loss of sod2 (mitochondrial SOD), but not of sod1 (cytosolic), causes a worsening of the recovery from ischemia/reperfusion that is similar to that observed with ABC-me ϩ/Ϫ hearts. 3 We selected EUK-207 for these experiments because it exerts both SOD and catalase activities. Similar pretreatments with a predominant SOD mimetic (eg, MnTBAP in cardiac ischemia/ reperfusion) have been shown to increase the accumulation of hydrogen peroxide and to impair recovery after ischemia/ reperfusion. 6 On the other hand, when MnTBAP was administered with catalase, recovery after ischemia/reperfusion was improved compared with hearts treated with catalase alone or untreated hearts. 6 Thus, it is likely that increasing both SOD and catalase activities, shortly before the onset of ischemia, is a better strategy to improve functional recovery from ischemia/reperfusion than short-term treatments predominantly increasing either SOD or catalase activities.
In contrast to the impaired response to ischemia/reperfusion, under basal conditions, ABC-me ϩ/Ϫ hearts have normal mitochondrial respiration and hemodynamic function. Under basal conditions, there was also no evidence of increased oxidative stress as reflected by protein carbonylation, the upregulation of sod2 and catalase protein expression, the production of mitochondrial superoxide, or the detection of oxidized SERCA. This finding further suggests that the impaired response to ischemia/reperfusion is not due to an increase in basal oxidative stress. The lack of a basal cardiac phenotype is similar to observations in sod2 ϩ/Ϫ mice. 3 A possible explanation for impaired mitochondrial oxidative status after ischemia/reperfusion is that partial loss of ABC-me affects heme synthesis and/or mitochondrial iron import in heart because ABC-me overexpression increases hemoglobinization and stabilizes the iron importer mitoferrin-1 in erythroid cell lines. 23, 25 Indeed, alterations in iron and/or in heme homeostasis are widely known to trigger mitochondrial dysfunction and/or oxidative stress. For example, the mouse heart model of Friedrich ataxia shows dramatic defects in mitochondrial iron homeostasis and is associated with a severe cardiac phenotype characterized by dilated cardiomyopathy at 4.5 to 9 weeks of age that is prevented by iron chelation. 37 In this model, there is a marked decrease in the level of the complex II subunit Sdha. 37 However, in marked contrast, ABC-me ϩ/Ϫ hearts have normal basal structure and function and do not develop dilated cardiomyopathy or changes in Sdha or mitoferrin-1 levels ( Figure IV in the online-only Data Supplement). Thus, it is unlikely that inactivation of 1 allele of ABC-me causes important defects in iron and/or heme homeostasis in heart under basal conditions.
Another potential explanation is that ABC-me transport activity is increased by ischemia/reperfusion and mediates protection from oxidative stress either by preventing the accumulation of molecules that would increase oxidative stress inside the mitochondria or by stimulating and/or enabling a cellular antioxidant response.
This study has potential clinical implications. First, these findings raise the possibility that genetic variations (mutations and/or polymorphisms) and/or drugs inactivating ABC-me may decrease tolerance for ischemia/reperfusion in humans. Second, this study demonstrates that pretreatment with antioxidants could be used to restore normal tolerance for ischemia/reperfusion in subjects showing genetic variations in ABC-me or to prevent the toxicity of drugs that could inactivate ABC-me.
